Overview

A Clinical Study to Evaluate Cyclopofol Injection for the Prevention of Postoperative Nausea and Vomiting

Status:
Enrolling by invitation
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
This study uses cyclopropofol as a positive control and adopts a large sample, multi-center, random, double-blind and positive parallel control test design to explore the clinical application value of cyclopropofol in preventing postoperative nausea and vomiting.
Phase:
Phase 1
Details
Lead Sponsor:
Mengchang Yang